APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metformin Hydrochloride Sustained-release Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Metformin Hydrochloride Sustained-release Tablets Industry Growth and Trends Forecast to 2032

22 December 2025114 pages

Choose your research edition.

Industry ResearchMetformin Hydrochloride Sustained-release Tablets Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Metformin Hydrochloride Sustained-release Tablets Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Metformin Hydrochloride Sustained-release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metformin Hydrochloride Sustained-release Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Metformin Hydrochloride Sustained-release Tablets Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Metformin Hydrochloride Sustained-release Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Metformin Hydrochloride Sustained-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Metformin Hydrochloride Sustained-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metformin Hydrochloride Sustained-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metformin Hydrochloride Sustained-release Tablets include Chongqing Conquer Pharmaceutical, CTTQ, Topfond Pharmaceutical, Teva Pharmaceuticals, CSPC, Shanghai Pharmaceuticals, Qingdao Huanghai Pharmaceutical, Merck and Jiangsu Deyuan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Metformin Hydrochloride Sustained-release Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Metformin Hydrochloride Sustained-release Tablets market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metformin Hydrochloride Sustained-release Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metformin Hydrochloride Sustained-release Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Metformin Hydrochloride Sustained-release Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Metformin Hydrochloride Sustained-release Tablets Market by Company

Chongqing Conquer Pharmaceutical

CTTQ

Topfond Pharmaceutical

Teva Pharmaceuticals

CSPC

Shanghai Pharmaceuticals

Qingdao Huanghai Pharmaceutical

Merck

Jiangsu Deyuan Pharmaceutical

Tianan Pharmaceutical

SinocorpPharma

Jingfeng Pharmaceutical Group

Viatris

Sun Pharmaceutical Industries

Dr. Reddy's Laboratories

Apotex

Metformin Hydrochloride Sustained-release Tablets Segment by Type

0.5g

0.25g

Metformin Hydrochloride Sustained-release Tablets Segment by Application

Hospital

Clinic

Other

Metformin Hydrochloride Sustained-release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Hydrochloride Sustained-release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metformin Hydrochloride Sustained-release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Hydrochloride Sustained-release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metformin Hydrochloride Sustained-release Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Metformin Hydrochloride Sustained-release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.5g Table 2. Major Company of 0.25g Table 3. Global Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021-2026) & (k units) Table 5. Global Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Metformin Hydrochloride Sustained-release Tablets Price by Type (2021-2026) & (US$/unit) Table 9. Global Metformin Hydrochloride Sustained-release Tablets Sales by Type (2027-2032) & (k units) Table 10. Global Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Metformin Hydrochloride Sustained-release Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Metformin Hydrochloride Sustained-release Tablets Price by Type (2027-2032) & (US$/unit) Table 14. North America Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021-2026) & (k units) Table 15. North America Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021-2026) & (k units) Table 17. Europe Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021-2026) & (k units) Table 21. Latin America Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Metformin Hydrochloride Sustained-release Tablets Industry Trends Table 25. Metformin Hydrochloride Sustained-release Tablets Industry Drivers Table 26. Metformin Hydrochloride Sustained-release Tablets Industry Opportunities and Challenges Table 27. Metformin Hydrochloride Sustained-release Tablets Industry Restraints Table 28. Global Metformin Hydrochloride Sustained-release Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Metformin Hydrochloride Sustained-release Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Metformin Hydrochloride Sustained-release Tablets Sales by Company (2021-2026) & (k units) Table 31. Global Metformin Hydrochloride Sustained-release Tablets Sales Share by Company (2021-2026) Table 32. Global Metformin Hydrochloride Sustained-release Tablets Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Metformin Hydrochloride Sustained-release Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Metformin Hydrochloride Sustained-release Tablets Major Company Production Sites and Headquarters Table 35. Global Metformin Hydrochloride Sustained-release Tablets Company, Product Type & Application Table 36. Global Metformin Hydrochloride Sustained-release Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Metformin Hydrochloride Sustained-release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Metformin Hydrochloride Sustained-release Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Metformin Hydrochloride Sustained-release Tablets Sales by Region (2021-2026) & (k units) Table 41. Global Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Metformin Hydrochloride Sustained-release Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Metformin Hydrochloride Sustained-release Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Metformin Hydrochloride Sustained-release Tablets Sales by Region (2027-2032) & (k units) Table 46. Global Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Metformin Hydrochloride Sustained-release Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Metformin Hydrochloride Sustained-release Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021-2026) & (k units) Table 52. Global Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Metformin Hydrochloride Sustained-release Tablets Price by Application (2021-2026) & (US$/unit) Table 56. Global Metformin Hydrochloride Sustained-release Tablets Sales by Application (2027-2032) & (k units) Table 57. Global Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Metformin Hydrochloride Sustained-release Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Metformin Hydrochloride Sustained-release Tablets Price by Application (2027-2032) & (US$/unit) Table 61. North America Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021-2026) & (k units) Table 62. North America Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021-2026) & (k units) Table 64. Europe Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021-2026) & (k units) Table 68. Latin America Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Chongqing Conquer Pharmaceutical Company Information Table 72. Chongqing Conquer Pharmaceutical Business Overview Table 73. Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 75. Chongqing Conquer Pharmaceutical Recent Development Table 76. CTTQ Company Information Table 77. CTTQ Business Overview Table 78. CTTQ Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. CTTQ Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 80. CTTQ Recent Development Table 81. Topfond Pharmaceutical Company Information Table 82. Topfond Pharmaceutical Business Overview Table 83. Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 85. Topfond Pharmaceutical Recent Development Table 86. Teva Pharmaceuticals Company Information Table 87. Teva Pharmaceuticals Business Overview Table 88. Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 90. Teva Pharmaceuticals Recent Development Table 91. CSPC Company Information Table 92. CSPC Business Overview Table 93. CSPC Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. CSPC Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 95. CSPC Recent Development Table 96. Shanghai Pharmaceuticals Company Information Table 97. Shanghai Pharmaceuticals Business Overview Table 98. Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 100. Shanghai Pharmaceuticals Recent Development Table 101. Qingdao Huanghai Pharmaceutical Company Information Table 102. Qingdao Huanghai Pharmaceutical Business Overview Table 103. Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 105. Qingdao Huanghai Pharmaceutical Recent Development Table 106. Merck Company Information Table 107. Merck Business Overview Table 108. Merck Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Merck Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 110. Merck Recent Development Table 111. Jiangsu Deyuan Pharmaceutical Company Information Table 112. Jiangsu Deyuan Pharmaceutical Business Overview Table 113. Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 115. Jiangsu Deyuan Pharmaceutical Recent Development Table 116. Tianan Pharmaceutical Company Information Table 117. Tianan Pharmaceutical Business Overview Table 118. Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 120. Tianan Pharmaceutical Recent Development Table 121. SinocorpPharma Company Information Table 122. SinocorpPharma Business Overview Table 123. SinocorpPharma Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. SinocorpPharma Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 125. SinocorpPharma Recent Development Table 126. Jingfeng Pharmaceutical Group Company Information Table 127. Jingfeng Pharmaceutical Group Business Overview Table 128. Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 130. Jingfeng Pharmaceutical Group Recent Development Table 131. Viatris Company Information Table 132. Viatris Business Overview Table 133. Viatris Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Viatris Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 135. Viatris Recent Development Table 136. Sun Pharmaceutical Industries Company Information Table 137. Sun Pharmaceutical Industries Business Overview Table 138. Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 140. Sun Pharmaceutical Industries Recent Development Table 141. Dr. Reddy's Laboratories Company Information Table 142. Dr. Reddy's Laboratories Business Overview Table 143. Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 145. Dr. Reddy's Laboratories Recent Development Table 146. Apotex Company Information Table 147. Apotex Business Overview Table 148. Apotex Metformin Hydrochloride Sustained-release Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Apotex Metformin Hydrochloride Sustained-release Tablets Product Portfolio Table 150. Apotex Recent Development Table 151. North America Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. North America Metformin Hydrochloride Sustained-release Tablets Sales by Country (2021-2026) & (k units) Table 153. North America Metformin Hydrochloride Sustained-release Tablets Sales Market Share by Country (2021-2026) Table 154. North America Metformin Hydrochloride Sustained-release Tablets Sales Forecast by Country (2027-2032) & (k units) Table 155. North America Metformin Hydrochloride Sustained-release Tablets Sales Market Share Forecast by Country (2027-2032) Table 156. North America Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America Metformin Hydrochloride Sustained-release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 158. North America Metformin Hydrochloride Sustained-release Tablets Market Share by Country (2021-2026) Table 159. North America Metformin Hydrochloride Sustained-release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America Metformin Hydrochloride Sustained-release Tablets Market Share Forecast by Country (2027-2032) Table 161. Europe Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Europe Metformin Hydrochloride Sustained-release Tablets Sales by Country (2021-2026) & (k units) Table 163. Europe Metformin Hydrochloride Sustained-release Tablets Sales Market Share by Country (2021-2026) Table 164. Europe Metformin Hydrochloride Sustained-release Tablets Sales Forecast by Country (2027-2032) & (k units) Table 165. Europe Metformin Hydrochloride Sustained-release Tablets Sales Market Share Forecast by Country (2027-2032) Table 166. Europe Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe Metformin Hydrochloride Sustained-release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe Metformin Hydrochloride Sustained-release Tablets Market Share by Country (2021-2026) Table 169. Europe Metformin Hydrochloride Sustained-release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe Metformin Hydrochloride Sustained-release Tablets Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales by Country (2021-2026) & (k units) Table 173. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales Forecast by Country (2027-2032) & (k units) Table 175. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Market Share by Country (2021-2026) Table 179. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Market Share Forecast by Country (2027-2032) Table 181. Latin America Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Latin America Metformin Hydrochloride Sustained-release Tablets Sales by Country (2021-2026) & (k units) Table 183. Latin America Metformin Hydrochloride Sustained-release Tablets Sales Market Share by Country (2021-2026) Table 184. Latin America Metformin Hydrochloride Sustained-release Tablets Sales Forecast by Country (2027-2032) & (k units) Table 185. Latin America Metformin Hydrochloride Sustained-release Tablets Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America Metformin Hydrochloride Sustained-release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America Metformin Hydrochloride Sustained-release Tablets Market Share by Country (2021-2026) Table 189. Latin America Metformin Hydrochloride Sustained-release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America Metformin Hydrochloride Sustained-release Tablets Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales by Country (2021-2026) & (k units) Table 193. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales Forecast by Country (2027-2032) & (k units) Table 195. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Market Share by Country (2021-2026) Table 199. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Metformin Hydrochloride Sustained-release Tablets Distributors List Table 204. Metformin Hydrochloride Sustained-release Tablets Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Metformin Hydrochloride Sustained-release Tablets Image Figure 2. Global Metformin Hydrochloride Sustained-release Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metformin Hydrochloride Sustained-release Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Metformin Hydrochloride Sustained-release Tablets Sales (2021-2032) & (k units) Figure 5. 0.5g Image Figure 6. Global 0.5g Sales YoY Growth (2021-2032) & (k units) Figure 7. 0.25g Image Figure 8. Global 0.25g Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Metformin Hydrochloride Sustained-release Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Metformin Hydrochloride Sustained-release Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Metformin Hydrochloride Sustained-release Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Metformin Hydrochloride Sustained-release Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Metformin Hydrochloride Sustained-release Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Metformin Hydrochloride Sustained-release Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Metformin Hydrochloride Sustained-release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Metformin Hydrochloride Sustained-release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Metformin Hydrochloride Sustained-release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Metformin Hydrochloride Sustained-release Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Metformin Hydrochloride Sustained-release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Metformin Hydrochloride Sustained-release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Metformin Hydrochloride Sustained-release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Metformin Hydrochloride Sustained-release Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Metformin Hydrochloride Sustained-release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Metformin Hydrochloride Sustained-release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Metformin Hydrochloride Sustained-release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Metformin Hydrochloride Sustained-release Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Metformin Hydrochloride Sustained-release Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5g
  • 0.25g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Conquer Pharmaceutical
  • CTTQ
  • Topfond Pharmaceutical
  • Teva Pharmaceuticals
  • CSPC
  • Shanghai Pharmaceuticals
  • Qingdao Huanghai Pharmaceutical
  • Merck
  • Jiangsu Deyuan Pharmaceutical
  • Tianan Pharmaceutical
  • SinocorpPharma
  • Jingfeng Pharmaceutical Group
  • Viatris
  • Sun Pharmaceutical Industries
  • Dr. Reddy's Laboratories
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Metformin Hydrochloride Sustained-release Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Metformin Hydrochloride Sustained-release Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Metformin Hydrochloride Sustained-release Tablets Market by Type
  6. 1.3.1 0.5g
  7. 1.3.2 0.25g
  8. 1.4 Global Metformin Hydrochloride Sustained-release Tablets Market Size by Type
  9. 1.4.1 Global Metformin Hydrochloride Sustained-release Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Metformin Hydrochloride Sustained-release Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Metformin Hydrochloride Sustained-release Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Metformin Hydrochloride Sustained-release Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Metformin Hydrochloride Sustained-release Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Metformin Hydrochloride Sustained-release Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Metformin Hydrochloride Sustained-release Tablets Industry Trends
  2. 2.2 Metformin Hydrochloride Sustained-release Tablets Industry Drivers
  3. 2.3 Metformin Hydrochloride Sustained-release Tablets Industry Opportunities and Challenges
  4. 2.4 Metformin Hydrochloride Sustained-release Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Metformin Hydrochloride Sustained-release Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Metformin Hydrochloride Sustained-release Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Metformin Hydrochloride Sustained-release Tablets Price (2021-2026)
  4. 3.4 Global Metformin Hydrochloride Sustained-release Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metformin Hydrochloride Sustained-release Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Metformin Hydrochloride Sustained-release Tablets Company, Product Type & Application
  7. 3.7 Global Metformin Hydrochloride Sustained-release Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metformin Hydrochloride Sustained-release Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metformin Hydrochloride Sustained-release Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metformin Hydrochloride Sustained-release Tablets Tier 1, Tier 2, and Tier 3
4 Metformin Hydrochloride Sustained-release Tablets Regional Status and Outlook
  1. 4.1 Global Metformin Hydrochloride Sustained-release Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Metformin Hydrochloride Sustained-release Tablets Historic Market Size by Region
  3. 4.2.1 Global Metformin Hydrochloride Sustained-release Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Metformin Hydrochloride Sustained-release Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Metformin Hydrochloride Sustained-release Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Metformin Hydrochloride Sustained-release Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Metformin Hydrochloride Sustained-release Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Metformin Hydrochloride Sustained-release Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Metformin Hydrochloride Sustained-release Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metformin Hydrochloride Sustained-release Tablets by Application
  1. 5.1 Metformin Hydrochloride Sustained-release Tablets Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Metformin Hydrochloride Sustained-release Tablets Market Size by Application
  6. 5.2.1 Global Metformin Hydrochloride Sustained-release Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Metformin Hydrochloride Sustained-release Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Metformin Hydrochloride Sustained-release Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Metformin Hydrochloride Sustained-release Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Metformin Hydrochloride Sustained-release Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Metformin Hydrochloride Sustained-release Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Conquer Pharmaceutical
  2. 6.1.1 Chongqing Conquer Pharmaceutical Company Information
  3. 6.1.2 Chongqing Conquer Pharmaceutical Business Overview
  4. 6.1.3 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  6. 6.1.5 Chongqing Conquer Pharmaceutical Recent Developments
  7. 6.2 CTTQ
  8. 6.2.1 CTTQ Company Information
  9. 6.2.2 CTTQ Business Overview
  10. 6.2.3 CTTQ Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CTTQ Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  12. 6.2.5 CTTQ Recent Developments
  13. 6.3 Topfond Pharmaceutical
  14. 6.3.1 Topfond Pharmaceutical Company Information
  15. 6.3.2 Topfond Pharmaceutical Business Overview
  16. 6.3.3 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  18. 6.3.5 Topfond Pharmaceutical Recent Developments
  19. 6.4 Teva Pharmaceuticals
  20. 6.4.1 Teva Pharmaceuticals Company Information
  21. 6.4.2 Teva Pharmaceuticals Business Overview
  22. 6.4.3 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  24. 6.4.5 Teva Pharmaceuticals Recent Developments
  25. 6.5 CSPC
  26. 6.5.1 CSPC Company Information
  27. 6.5.2 CSPC Business Overview
  28. 6.5.3 CSPC Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CSPC Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  30. 6.5.5 CSPC Recent Developments
  31. 6.6 Shanghai Pharmaceuticals
  32. 6.6.1 Shanghai Pharmaceuticals Company Information
  33. 6.6.2 Shanghai Pharmaceuticals Business Overview
  34. 6.6.3 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  36. 6.6.5 Shanghai Pharmaceuticals Recent Developments
  37. 6.7 Qingdao Huanghai Pharmaceutical
  38. 6.7.1 Qingdao Huanghai Pharmaceutical Company Information
  39. 6.7.2 Qingdao Huanghai Pharmaceutical Business Overview
  40. 6.7.3 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  42. 6.7.5 Qingdao Huanghai Pharmaceutical Recent Developments
  43. 6.8 Merck
  44. 6.8.1 Merck Company Information
  45. 6.8.2 Merck Business Overview
  46. 6.8.3 Merck Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  48. 6.8.5 Merck Recent Developments
  49. 6.9 Jiangsu Deyuan Pharmaceutical
  50. 6.9.1 Jiangsu Deyuan Pharmaceutical Company Information
  51. 6.9.2 Jiangsu Deyuan Pharmaceutical Business Overview
  52. 6.9.3 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  54. 6.9.5 Jiangsu Deyuan Pharmaceutical Recent Developments
  55. 6.10 Tianan Pharmaceutical
  56. 6.10.1 Tianan Pharmaceutical Company Information
  57. 6.10.2 Tianan Pharmaceutical Business Overview
  58. 6.10.3 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  60. 6.10.5 Tianan Pharmaceutical Recent Developments
  61. 6.11 SinocorpPharma
  62. 6.11.1 SinocorpPharma Company Information
  63. 6.11.2 SinocorpPharma Business Overview
  64. 6.11.3 SinocorpPharma Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 SinocorpPharma Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  66. 6.11.5 SinocorpPharma Recent Developments
  67. 6.12 Jingfeng Pharmaceutical Group
  68. 6.12.1 Jingfeng Pharmaceutical Group Company Information
  69. 6.12.2 Jingfeng Pharmaceutical Group Business Overview
  70. 6.12.3 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  72. 6.12.5 Jingfeng Pharmaceutical Group Recent Developments
  73. 6.13 Viatris
  74. 6.13.1 Viatris Company Information
  75. 6.13.2 Viatris Business Overview
  76. 6.13.3 Viatris Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Viatris Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  78. 6.13.5 Viatris Recent Developments
  79. 6.14 Sun Pharmaceutical Industries
  80. 6.14.1 Sun Pharmaceutical Industries Company Information
  81. 6.14.2 Sun Pharmaceutical Industries Business Overview
  82. 6.14.3 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  84. 6.14.5 Sun Pharmaceutical Industries Recent Developments
  85. 6.15 Dr. Reddy's Laboratories
  86. 6.15.1 Dr. Reddy's Laboratories Company Information
  87. 6.15.2 Dr. Reddy's Laboratories Business Overview
  88. 6.15.3 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  90. 6.15.5 Dr. Reddy's Laboratories Recent Developments
  91. 6.16 Apotex
  92. 6.16.1 Apotex Company Information
  93. 6.16.2 Apotex Business Overview
  94. 6.16.3 Apotex Metformin Hydrochloride Sustained-release Tablets Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Apotex Metformin Hydrochloride Sustained-release Tablets Product Portfolio
  96. 6.16.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America Metformin Hydrochloride Sustained-release Tablets Sales by Country
  2. 7.1.1 North America Metformin Hydrochloride Sustained-release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Metformin Hydrochloride Sustained-release Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Metformin Hydrochloride Sustained-release Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Metformin Hydrochloride Sustained-release Tablets Market Size by Country
  6. 7.2.1 North America Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Metformin Hydrochloride Sustained-release Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Metformin Hydrochloride Sustained-release Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Metformin Hydrochloride Sustained-release Tablets Sales by Country
  2. 8.1.1 Europe Metformin Hydrochloride Sustained-release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Metformin Hydrochloride Sustained-release Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Metformin Hydrochloride Sustained-release Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Metformin Hydrochloride Sustained-release Tablets Market Size by Country
  6. 8.2.1 Europe Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Metformin Hydrochloride Sustained-release Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Metformin Hydrochloride Sustained-release Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Metformin Hydrochloride Sustained-release Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Metformin Hydrochloride Sustained-release Tablets Sales by Country
  2. 10.1.1 South America Metformin Hydrochloride Sustained-release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Metformin Hydrochloride Sustained-release Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Metformin Hydrochloride Sustained-release Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Metformin Hydrochloride Sustained-release Tablets Market Size by Country
  6. 10.2.1 South America Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Metformin Hydrochloride Sustained-release Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Metformin Hydrochloride Sustained-release Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Metformin Hydrochloride Sustained-release Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Metformin Hydrochloride Sustained-release Tablets Value Chain Analysis
  2. 12.1.1 Metformin Hydrochloride Sustained-release Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Metformin Hydrochloride Sustained-release Tablets Production Mode & Process
  7. 12.2 Metformin Hydrochloride Sustained-release Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Metformin Hydrochloride Sustained-release Tablets Distributors
  10. 12.2.3 Metformin Hydrochloride Sustained-release Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst